Glucose-insulin-potassium administration in acute myocardial infarction.
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000008:administration & dosage*; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy*; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D011188:Potassium / Q000008:administration & dosage*; D011446:Prospective Studies; D011897:Random Allocation
D000889:Anti-Arrhythmia Agents; D005230:Fatty Acids, Nonesterified; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium